GDRX logo

GoodRx Holdings (GDRX) Selling, general & administrative expenses

annual SGA:

$484.98M+$18.13M(+3.88%)
December 31, 2024

Summary

  • As of today (May 24, 2025), GDRX annual SGA is $484.98 million, with the most recent change of +$18.13 million (+3.88%) on December 31, 2024.
  • During the last 3 years, GDRX annual SGA has fallen by -$39.93 million (-7.61%).
  • GDRX annual SGA is now -32.32% below its all-time high of $716.59 million, reached on December 31, 2020.

Performance

GDRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

quarterly SGA:

$114.17M-$3.20M(-2.73%)
March 31, 2025

Summary

  • As of today (May 24, 2025), GDRX quarterly SGA is $114.17 million, with the most recent change of -$3.20 million (-2.73%) on March 31, 2025.
  • Over the past year, GDRX quarterly SGA has dropped by -$16.90 million (-12.89%).
  • GDRX quarterly SGA is now -72.53% below its all-time high of $415.69 million, reached on December 31, 2020.

Performance

GDRX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

TTM SGA:

-$5.77B+$28.45M(+0.49%)
March 31, 2025

Summary

  • As of today (May 24, 2025), GDRX TTM SGA is -$5.77 billion, with the most recent change of +$28.45 million (+0.49%) on March 31, 2025.
  • Over the past year, GDRX TTM SGA has dropped by -$6.26 billion (-1278.19%).
  • GDRX TTM SGA is now -426.10% below its all-time high of -$1.10 billion.

Performance

GDRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

GDRX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.9%-12.9%-1278.2%
3 y3 years-7.6%-8.6%-1196.4%
5 y5 years+153.0%+65.3%-3360.9%

GDRX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.6%+3.9%-15.9%+6.1%-3.9%+0.8%
5 y5-year-32.3%+153.0%-72.5%+96.0%-169.8%+0.8%
alltimeall time-32.3%+330.9%-72.5%+132.8%-426.1%+0.8%

GDRX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$114.17M(-2.7%)
$468.08M(-3.5%)
Dec 2024
$484.98M(+3.9%)
$117.38M(+1.6%)
$484.98M(-1.4%)
Sep 2024
-
$115.49M(-4.6%)
$491.72M(-2.3%)
Jun 2024
-
$121.04M(-7.7%)
$503.17M(+2.7%)
Mar 2024
-
$131.07M(+5.6%)
$489.77M(+4.9%)
Dec 2023
$466.84M(-7.1%)
$124.12M(-2.2%)
$466.84M(+2.5%)
Sep 2023
-
$126.93M(+17.9%)
$455.43M(-1.9%)
Jun 2023
-
$107.65M(-0.5%)
$464.26M(-4.4%)
Mar 2023
-
$108.14M(-4.1%)
$485.69M(-3.3%)
Dec 2022
$502.42M
$112.71M(-17.0%)
$502.42M(-5.5%)
Sep 2022
-
$135.76M(+5.2%)
$531.58M(+0.8%)
Jun 2022
-
$129.08M(+3.4%)
$527.41M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
$124.87M(-12.0%)
$526.30M(+0.3%)
Dec 2021
$524.90M(-26.7%)
$141.87M(+7.8%)
$524.90M(-34.3%)
Sep 2021
-
$131.60M(+2.8%)
$798.73M(-5.0%)
Jun 2021
-
$127.96M(+3.6%)
$840.73M(+9.0%)
Mar 2021
-
$123.48M(-70.3%)
$771.02M(+7.6%)
Dec 2020
$716.59M(+273.9%)
$415.69M(+139.5%)
$716.59M(+99.2%)
Sep 2020
-
$173.59M(+198.0%)
$359.75M(+52.9%)
Jun 2020
-
$58.25M(-15.6%)
$235.21M(+32.9%)
Mar 2020
-
$69.05M(+17.3%)
$176.96M(+64.0%)
Dec 2019
$191.66M(+70.3%)
$58.85M(+20.0%)
$107.91M(+120.0%)
Sep 2019
-
$49.05M
$49.05M
Dec 2018
$112.54M
-
-

FAQ

  • What is GoodRx Holdings annual SGA?
  • What is the all time high annual SGA for GoodRx Holdings?
  • What is GoodRx Holdings annual SGA year-on-year change?
  • What is GoodRx Holdings quarterly SGA?
  • What is the all time high quarterly SGA for GoodRx Holdings?
  • What is GoodRx Holdings quarterly SGA year-on-year change?
  • What is GoodRx Holdings TTM SGA?
  • What is the all time high TTM SGA for GoodRx Holdings?
  • What is GoodRx Holdings TTM SGA year-on-year change?

What is GoodRx Holdings annual SGA?

The current annual SGA of GDRX is $484.98M

What is the all time high annual SGA for GoodRx Holdings?

GoodRx Holdings all-time high annual SGA is $716.59M

What is GoodRx Holdings annual SGA year-on-year change?

Over the past year, GDRX annual SGA has changed by +$18.13M (+3.88%)

What is GoodRx Holdings quarterly SGA?

The current quarterly SGA of GDRX is $114.17M

What is the all time high quarterly SGA for GoodRx Holdings?

GoodRx Holdings all-time high quarterly SGA is $415.69M

What is GoodRx Holdings quarterly SGA year-on-year change?

Over the past year, GDRX quarterly SGA has changed by -$16.90M (-12.89%)

What is GoodRx Holdings TTM SGA?

The current TTM SGA of GDRX is -$5.77B

What is the all time high TTM SGA for GoodRx Holdings?

GoodRx Holdings all-time high TTM SGA is -$1.10B

What is GoodRx Holdings TTM SGA year-on-year change?

Over the past year, GDRX TTM SGA has changed by -$6.26B (-1278.19%)
On this page